PALATIN TECHNOLOGIES, INC. Cash and Restricted Cash
PALATIN TECHNOLOGIES, INC. (PTN) had Cash and Restricted Cash of $10.16 million as of 2026-03-31, per its 10-Q filed 2026-05-13.
Financial Statements › Cash Flow
us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents · last filed 2026-05-13
- 2026-03-31: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $10.16M.
- 2025-12-31: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $14.48M.
- 2025-09-30: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $1.27M.
- 2025-06-30: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $2.56M.
| Period end | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
|---|---|
| 2026-03-31 | $10.16M 10-Q · filed 2026-05-13 |
| 2025-12-31 | $14.48M 10-Q · filed 2026-02-17 |
| 2025-09-30 | $1.27M 10-Q · filed 2025-11-14 |
| 2025-06-30 | $2.56M 10-Q · filed 2026-05-13 |
| 2025-03-31 | $2.52M 10-Q · filed 2026-05-13 |
| 2024-12-31 | $3.42M 10-Q · filed 2026-02-17 |
| 2024-09-30 | $2.38M 10-Q · filed 2025-11-14 |
| 2024-06-30 | $9.53M 10-Q · filed 2026-05-13 |
| 2024-03-31 | $10.01M 10-Q · filed 2025-05-14 |
| 2023-12-31 | $9.49M 10-Q · filed 2025-02-13 |
| 2023-09-30 | $5.52M 10-Q · filed 2024-11-14 |
| 2023-06-30 | $7.99M 10-K · filed 2025-09-23 |
| 2023-03-31 | $19.63M 10-Q · filed 2024-05-15 |
| 2022-12-31 | $21.18M 10-Q · filed 2024-02-14 |
| 2022-09-30 | $21.19M 10-Q · filed 2023-11-14 |
| 2022-06-30 | $29.94M 10-K · filed 2024-09-30 |
| 2022-03-31 | $37.72M 10-Q · filed 2023-05-15 |
| 2021-12-31 | $47.33M 10-Q · filed 2023-02-14 |
| 2021-09-30 | $53.42M 10-Q · filed 2022-11-14 |
| 2021-06-30 | $60.10M 10-K · filed 2023-09-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Korsana Biosciences, Inc. (CYCN) | United States | $0.016B | |
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B |